Browse all 3 CVE security advisories affecting Becton, Dickinson and Company. AI-powered Chinese analysis, POCs, and references for each vulnerability.
Becton, Dickinson and Company is a global medical technology firm specializing in medication delivery systems, diagnostic instruments, and laboratory supplies. Historically, their products have faced vulnerabilities including remote code execution, cross-site scripting, and privilege escalation, often stemming from web interfaces and network-connected devices. While no major public security incidents have been widely reported, the company maintains a moderate CVE count, reflecting typical risks in connected medical devices. Their security posture emphasizes regulatory compliance and device hardening, though legacy systems may present exposure points. The organization continues to address vulnerabilities through regular patching and security assessments to maintain HIPAA compliance and patient data protection.
| CVE ID | Title | CVSS | Severity | Published |
|---|---|---|---|---|
| CVE-2018-14786 | 多款BD产品授权问题漏洞 — Alaris GS, Alaris GH, Alaris CC, and Alaris TIVACWE-287 | 9.8 | - | 2018-08-23 |
| CVE-2018-10593 | BD DB Manager和PerformA 安全漏洞 — Kiestra and InoqulA systemsCWE-356 | 6.4 | - | 2018-05-24 |
| CVE-2018-10595 | BD ReadA 安全漏洞 — Kiestra and InoqulA systemsCWE-356 | 6.4 | - | 2018-05-24 |
This page lists every published CVE security advisory associated with Becton, Dickinson and Company. Each entry links to a detailed page with CVSS scoring, CWE classification, affected products and references. AI-generated Chinese analysis is provided for fast triage.